Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term transformation. Found 40 abstracts

no pagination
Chitalia A, Swoboda DM, McCutcheon JN, Ozdemirli M, Khan N, Cheson BD. Descriptive analysis of genetic aberrations and cell of origin in Richter transformation. Leukemia & lymphoma. 2019 Apr;60(4):971-9.
Tao Y, Kang B, Petkovich DA, Bhandari YR, In J, Stein-O'Brien G, Kong X, Xie W, Zachos N, Maegawa S, Vaidya H, Brown S, Chiu Yen RW, Shao X, Thakor J, Lu Z, Cai Y, Zhang Y, Mallona I, Peinado MA, Zahnow CA, Ahuja N, Fertig E, Issa JP, Baylin SB, Easwaran H. Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf(V600E)-Induced Tumorigenesis. Cancer cell. 2019 Feb 11;35(2):315-328e6.   PMCID: PMC6636642
Shi X, Ba R, You H, Jiang Q, Huang J, Mao J, Han L, Zhang S, Zhuang Q, Yu X, Wang L, Wang Y, Li D, Zhu W, Zhang Y, Zhu Y, Xi X. A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation. Frontiers of medicine. 2018 Jun;12(3):324-9.
Cruz OV, Prudnikova TY, Araiza-Olivera D, Perez-Plasencia C, Johnson N, Bernhardy AJ, Slifker M, Renner C, Chernoff J, Arias-Romero LE. Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition. Oncotarget. 2016 Nov;7(47):76590-603.   PMCID: PMC5363532
Villamar Cruz O, Prudnikova TY, Araiza-Olivera D, Perez-Plasencia C, Johnson N, Bernhardy AJ, Slifker M, Renner C, Chernoff J, Arias-Romero LE. Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition. Oncotarget. 2016 Oct 11;7(47):76590-603.   PMCID: PMC5363532
Menges CW, Sementino E, Talarchek J, Xu JF, Chernoff J, Peterson JR, Testa JR. Group I p21-Activated Kinases (PAKs) Promote Tumor Cell Proliferation and Survival through the AKT1 and Raf-MAPK Pathways. Molecular Cancer Research. 2012 Sep;10(9):1178-88.   PMCID: PMC3447107
Fedele M, Visone R, De Martino I, Palmieri D, Valentino T, Esposito F, Klein-Szanto A, Arra C, Ciarmiello A, Croce CM, Fusco A. Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice. European Journal of Cancer. 2011 Feb;47(3):470-8.   PMCID: not NIH funded
Tan YF, Cheung M, Pei JM, Menges CW, Godwin AK, Testa JR. Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling. Cancer Research. 2010 Nov;70(22):9197-206.   PMCID: PMCID: PMC3018149 [Available on 2011/11/1]
Shukla A, Bosenberg MW, MacPherson MB, Butnor KJ, Heintz NH, Pass HI, Carbone M, Testa JR, Mossman BT. Activated cAMP Response Element Binding Protein Is Overexpressed in Human Mesotheliomas and Inhibits Apoptosis. American Journal of Pathology. 2009 Nov;175(5):2197-206.   PMCID: PMC 2774081
Beeser A, Jaffer ZM, Hofmann C, Chernoff J. Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. Journal of Biological Chemistry. 2005 Nov 04;280(44):36609-15.
Mello ML, Lareef MH, Santos AB, Russo J, Vidal BC. Nucleus image properties and cell death in MCF-10F cells grown on slide substrates differing in nature and size. In Vitro Cell Dev. Biology Anim. Semin Oncol. 2005 Mar;41(3-4):92-6.
Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH. Breast differentiation and its implication in cancer prevention. Clinical Cancer Research. 2005 Jan 15;11(2):931S-936S.
Antonyak MA, Kenyon LC, Godwin AK, James DC, Emlet DR, Okamoto I, Tnani M, Holgado-Madruga M, Moscatello DK, Wong AJ. Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene. 2002 Aug;21(33):5038-46.
Abdollahi A, Bao R, Hamilton TC. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene. 1999 Nov 11;18(47):6477-87.
Barbisan LF, Mello ML, Russo J, Vidal BD. Apoptosis and catastrophic cell death in benzo a pyrene- transformed human breast epithelial cells. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 1999 Dec 16;431(1):133-9.
Mello ML, Barbisan LF, Russo J, Vidal BD. RNA relocation at mitosis in transformed and tumorigenic human breast epithelial cells. Cell biology international. 1999 Jan;23(2):125-8.
Mello ML, Vidal BD, Russo J. Ha-ras oncogene effect on DNA content and chromatin supraorganization in benzo a pyrene-transformed human breast epithelial cells. Analytical Cellular Pathology. 1999 Jan;19(2):73-9.
Russo J, Russo IH. Cellular basis of breast cancer susceptibility. Oncology Research. 1999 Jan;11(4):169-78.
Hu YF, Lau KM, Ho SM, Russo J. Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. International Journal of Oncology. 1998 Jun;12(6):1225-8.
Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA, Kovar H. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene. 1998 Aug 06;17(5):603-10.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term transformation

transformation tumorigenesis apoptosis chemical carcinogens activation cancer transcription ha-ras cell DNA repair Pak1 proliferation carcinogenesis risk fibroblasts small molecule inhibitor line constitutive activation human-breast-cancer mediated creb phosphorylation protein-kinase cell of origin estrogen receptor breast epithelial cells deregulation myxoid liposarcoma efficacy lobules substrates MCF-10F cells-nuclear image-cell death malignant mesothelioma b-raf development raf activation tamoxifen nf2 dependent activation induction homeobox gene-expression human dependent pathway growth cytochemistry hela-cells 1993 guchi t-cancer research-v53-p4349 transgenic mice nucleolus-like bodies c-Ha-ras phosphatidylinositol 3-kinase hmgi-c gene signal-transduction estrogen receptor-beta gene Lymphoma Adipogenesis-Experimental animal models-Oncogene-E2F1-High Mobility Group proteins chromosome-translocation natural-killer-cell calcium regulation Cimp ews CpG-island DNA methylation brain tumor pathogenesis c-myc c-jun signal-regulated kinase-1 ovarian-cancer prophylactic mastectomy human breast epithelial cell MCF-10F transcription factor-tfiib endonuclease merlin Fanconi Anemia benign mesenchymal tumors myeloid chromosome-17 LOT1 tyrosine phosphorylation sigma factors n-terminal kinase RNA Braf(v600e) epidermal growth factor serine-338 phosphorylation Ki67 TGF-alpha estrogen-receptor-beta EGF receptor texture splenic lymphoma with villous lymphocytes two-hybrid-system liver transcriptional activation chemical-carcinogens inhibitor cancer-cells kinase-c-delta aging nuclear phenotypes epithelial-cells glioblastoma multiforme carcinogens women okadaic acid protein-kinases epidermal growth-factor breast cancer targets birth growth-factor mitosis lung epithelial-cells in-vitro factor-i receptor cancer risk chromatin texture splenic marginal zone lymphoma surface epithelial-cells progesterone receptor growth-factor-receptor lung-carcinoma cells defined medium age EGFR breast epithelial-cells asbestos mesothelioma gene mutation analysis dna-binding binding protein tumor predisposition regulated kinase erk expression incessant ovulation ovary mammary epithelial-cells breast suppresses growth Richter transformation signaling pathway Fanconi anemia microcell-mediated transfer pituitary-adenomas benzo[a]pyrene MAP kinase inhibition ewings-sarcoma translocation epigenetic silencing chromosome translocation colon adenocarcinomas
Last updated on Wednesday, February 05, 2020